Vivoiz Healthtech Profile
Key Indicators
- Authorised Capital ₹ 0.37 M
as on 10-12-2024
- Paid Up Capital ₹ 0.16 M
as on 10-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.51 Cr
as on 10-12-2024
- Satisfied Charges ₹ 12.02 Cr
as on 10-12-2024
- Revenue 23.07%
(FY 2024)
- Profit 47.57%
(FY 2024)
- Ebitda 45.29%
(FY 2024)
- Net Worth -23.62%
(FY 2024)
- Total Assets -17.00%
(FY 2024)
About Vivoiz Healthtech
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.37 M and a paid-up capital of Rs 0.16 M.
The company currently has active open charges totaling ₹12.51 Cr. The company has closed loans amounting to ₹12.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Palepu Rao, Gaurav Aggarwal, and Prasoon Thapliyal serve as directors at the Company.
- CIN/LLPIN
U85100DL2016PTC289331
- Company No.
289331
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Vivoiz Healthtech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Aggarwal  | Director | 05-Jan-2016 | Current |
| Palepu Rao | Nominee Director | 03-Jan-2023 | Current |
| Prasoon Thapliyal | Director | 01-Sep-2021 | Current |
Financial Performance of Vivoiz Healthtech.
Vivoiz Healthtech Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 23.07% increase. The company also saw a substantial improvement in profitability, with a 47.57% increase in profit. The company's net worth observed a substantial decline by a decrease of 23.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivoiz Healthtech?
In 2024, Vivoiz Healthtech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Apr 2024 | ₹7.51 Cr | Open |
Others Creation Date: 29 Jan 2024 | ₹2.00 Cr | Open |
Others Creation Date: 29 Jan 2024 | ₹3.00 Cr | Open |
How Many Employees Work at Vivoiz Healthtech?
Vivoiz Healthtech has a workforce of 67 employees as of Dec 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivoiz Healthtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivoiz Healthtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
